MabSpace engages in the research and development of therapeutic antibodies for the treatment of cancer... Read more
MabSpace engages in the research and development of therapeutic antibodies for the treatment of cancer... Read more
News
Jan 03, 2019
Pharmabiz
MabSpace Biosciences: HJB merges with MabSpace to create fully integrated global biotherapeutics company, Transcenta Holding
Jan 03, 2019
Pipeline Review
MabSpace Biosciences: HJB Merges with MabSpace Biosciences to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company
Jan 03, 2019
Yicai Global
MabSpace Biosciences: Chinese Pharma Startups Aim to Boost R&D Through Merger
Jan 02, 2019
BioPharma-Reporter
MabSpace Biosciences: Biotherapeutics companies to 'achieve critical mass' after merger
Sep 06, 2018
4-traders
MabSpace Biosciences: MabSpace Biosciences Doses First Patient in China Phase 1 Trial for MSB2311 and Submitted IND for MSB0254 to NMPA
May 11, 2018
Asian Venture Capital Journal
MabSpace Biosciences: Sequoia leads $40m round for Hong Kong biotech player
May 11, 2018
BioPortfolio
MabSpace Biosciences: MabSpace Biosciences of Suzhou Closes $40 Million B Round
May 10, 2018
BioCentury
MabSpace Biosciences: Chinese companies MabSpace and ICT announce series B rounds
Apr 14, 2018
BioPortfolio
MabSpace Biosciences: MabSpace Starts US Trial of PDL1 Drug; China Trial to Begin Soon
Apr 13, 2018
BioPortfolio
MabSpace Biosciences: MabSpace Initiated Global Phase 1 Trial of MSB2311 Its 2nd Generation PDL1 Antibody With a Distinct IntraTumor Recycling Property
MabSpace Biosciences Competitors
1
2
3
4
5
6
7
8
9
10